View this email as a web page here.
Are you up to date on the latest developments in coronavirus therapies and diagnostics?
Your update of the most recent news in drug discovery and development efforts
June 4, 2020
Targeted drugs and immunotherapies may lower risk of hematologic cancers

Trend of reduced therapy-related hematologic cancers among patients with three cancer types likely driven by immune modulation, Roswell Park team proposes ...more >

Platform shows its mettle with kidney disease and COVID

Delta 4 announces that encouraging results have been achieved with its drug discovery 
technology ... more >

A boost for cancer immunotherapy

Engineers at the Massachusetts Institute of Technology design nanoparticles that stimulate the immune system and help it attack tumors ...more >

Aiming to better tackle relapse

Purdue startup gets $2-million SBIR grant to fast-track cancer drug platform technology ...more >

Radiation-induced lung injury: Is there finally an approved treatment on the way?

Aqualung Therapeutics receives a $2.3-million award to develop a novel therapeutic antibody for patients with radiation-induced lung injury...more >

Thermo NL - June 04  Reveal_-DDN_300x100
COVID-19 helps boost the move toward virtual trials

ERT survey indicates many companies and organziations are implementing elements of virtual trials due to the pandemic ...more >

COVID-19 study funding extended after positive preliminary data

Study in California is utilizing IVIG as investigational coronavirus treatment for adults experiencing respiratory failure ...more >